Genome Editing Market Report: Trends, Forecast and Competitive Analysis
Get it in 2 to 4 weeks by ordering today
The future of the genome editing market looks promising with opportunities in cell line engineering, animal genetic engineering, and plant genetic engineering applications. The global genome editing market is expected to grow with a CAGR of 15%-20% from 2020 to 2025. The major drivers for this market are rising government funding and growth in the number of genomics projects and expanding application areas of genomics.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global genome editing market report, please download the report brochure.
In this market, CRISPR is the largest technology of genome editing, whereas biotechnology & pharmaceutical companies is the largest end use. Growth in various segments of the genome editing market are given below:
The study includes trends and forecast for the global genome editing market by technology, delivery method, application, service, end use, and region as follows:
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
Lucintel forecasts that CRISPR will remain the largest technology segment over the forecast period, as it can be tailored to treat patient-specific mutations for genetic diseases.
Within this market, biotechnology & pharmaceutical companies will remain the largest end use segment over the forecast period due to the large number of research projects carried out in gene engineering for the development of novel therapeutics.
North America will remain the largest region over the forecast period due to higher adoption of advanced techniques in the research institutes based in the US and higher incidence of monogenic diseases in the region.
Features of the Global Genome Editing Market
Q.1 What are some of the most promising potential, high-growth opportunities for the global genome editing market by technology (CRISPR/CAS9, TALENs, ZFN, and others), delivery method (ex-vivo and in-vivo), application (cell line engineering, animal genetic engineering, plant genetic engineering, and other applications), service (contract and in-house), end use (biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global genome editing market?
Q.5 What are the business risks and threats to the global genome editing market?
Q.6 What are the emerging trends in this genome editing market and the reasons behind them?
Q.7 What are some changing demands of customers in this genome editing market?
Q.8 What are the new developments in this genome editing market? Which companies are leading these developments?
Q.9 Who are the major players in this genome editing market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this genome editing market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global genome editing market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Technology Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Technology (CRISPR/Cas9, TALENs, ZFN, and Others), Delivery Method (Ex-Vivo and In-Vivo), Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications), Service (Contract and In-House), and End Use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
The future of the genome editing market looks promising with opportunities in cell line engineering, animal genetic engineering, and plant genetic engineering applications. The global genome editing market is expected to grow with a CAGR of 15%-20% from 2020 to 2025. The major drivers for this market are rising government funding and growth in the number of genomics projects and expanding application areas of genomics.
A total of XX figures / charts and XX tables are provided in this more than 150-pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global genome editing market report, please download the report brochure.
In this market, CRISPR is the largest technology of genome editing, whereas biotechnology & pharmaceutical companies is the largest end use. Growth in various segments of the genome editing market are given below:
The study includes trends and forecast for the global genome editing market by technology, delivery method, application, service, end use, and region as follows:
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- CRISPR/Cas9
- TALENs
- ZFN
- Others
- Ex-Vivo
- In-Vivo
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
- Other Applications
- Contract
- In-House
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutes
- Contract Research Organizations
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Spain
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Lucintel forecasts that CRISPR will remain the largest technology segment over the forecast period, as it can be tailored to treat patient-specific mutations for genetic diseases.
Within this market, biotechnology & pharmaceutical companies will remain the largest end use segment over the forecast period due to the large number of research projects carried out in gene engineering for the development of novel therapeutics.
North America will remain the largest region over the forecast period due to higher adoption of advanced techniques in the research institutes based in the US and higher incidence of monogenic diseases in the region.
Features of the Global Genome Editing Market
- Market Size Estimates: Global genome editing market size estimation in terms of value ($M) shipment.
- Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
- Segmentation Analysis: Global genome editing market size by various segments, such as technology, delivery method, application, service, and end use in terms of value.
- Regional Analysis: Global genome editing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different technology, delivery method, application, service, end use, and region for the global genome editing market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global genome editing market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Q.1 What are some of the most promising potential, high-growth opportunities for the global genome editing market by technology (CRISPR/CAS9, TALENs, ZFN, and others), delivery method (ex-vivo and in-vivo), application (cell line engineering, animal genetic engineering, plant genetic engineering, and other applications), service (contract and in-house), end use (biotechnology & pharmaceutical companies, academic & government research institutes, and contract research organizations), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global genome editing market?
Q.5 What are the business risks and threats to the global genome editing market?
Q.6 What are the emerging trends in this genome editing market and the reasons behind them?
Q.7 What are some changing demands of customers in this genome editing market?
Q.8 What are the new developments in this genome editing market? Which companies are leading these developments?
Q.9 Who are the major players in this genome editing market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this genome editing market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global genome editing market?
Report Scope
Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates) 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecasts, Competitor Analysis, New Technology Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Technology (CRISPR/Cas9, TALENs, ZFN, and Others), Delivery Method (Ex-Vivo and In-Vivo), Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications), Service (Contract and In-House), and End Use (Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations)
Regional Scope North America (USA, Mexico, and Canada), Europe (United Kingdom, Spain, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost
1. EXECUTIVE SUMMARY
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Genome Editing Market Trends and Forecast
3.3: Global Genome Editing Market by Technology
3.3.1: CRISPR/Cas9
3.3.2: TALENs
3.3.3: ZFN
3.3.4: Others
3.4: Global Genome Editing Market by Delivery Method
3.4.1: Ex-Viv
3.4.2: In-Viv
3.5: Global Genome Editing Market by Application
3.5.1: Cell Line Engineering
3.5.2: Animal Genetic Engineering
3.5.3: Plant Genetic Engineering
3.5.4: Other Applications
3.6: Global Genome Editing Market by Service
3.6.1: Contract
3.6.2: In-House
3.7: Global Genome Editing Market by End Use
3.7.1: Biotechnology & Pharmaceutical Companies
3.7.2: Academic & Government Research Institutes
3.7.3: Contract Research Organizations
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Genome Editing Market by Region
4.2: North American Genome Editing Market
4.2.1: Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.2.2: Market by Delivery Method: Ex-Vivo and In-Vivo
4.2.3: Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.2.4: Market by Service: Contract and In-House
4.2.5: Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.2.6: The United States Genome Editing Market
4.2.7: The Canadian Genome Editing Market
4.2.8: The Mexican Genome Editing Market
4.3: European Genome Editing Market
4.3.1: Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.3.2: Market by Delivery Method: Ex-Vivo and In-Vivo
4.3.3: Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.2.4: Market by Service: Contract and In-House
4.2.5: Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.3.6: The United Kingdom Genome Editing Market
4.3.7: The Spanish Genome Editing Market
4.3.8: The German Genome Editing Market
4.3.9: The French Genome Editing Market
4.4: APAC Genome Editing Market
4.4.1: Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.4.2: Market by Delivery Method: Ex-Vivo and In-Vivo
4.4.3: Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.4.4: Market by Service: Contract and In-House
4.4.5: Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.4.6: The Chinese Genome Editing Market
4.4.7: The Indian Genome Editing Market
4.4.8: The Japanese Genome Editing Market
4.5: ROW Genome Editing Market
4.5.1: Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.5.2: Market by Delivery Method: Ex-Vivo and In-Vivo
4.5.3: Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.5.4: Market by Service: Contract and In-House
4.5.5: Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.5.6: Brazilian Genome Editing Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Technology Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Genome Editing Market by Technology
7.1.2: Growth Opportunities for the Global Genome Editing Market by Delivery Method
7.1.3: Growth Opportunities for the Global Genome Editing Market by Application
7.1.4: Growth Opportunities for the Global Genome Editing Market by Service
7.1.5: Growth Opportunities for the Global Genome Editing Market by End Use
7.1.6: Growth Opportunities for the Global Genome Editing Market by Region
7.2: Emerging Trends in the Global Genome Editing Market
7.3: Strategic Analysis
7.3.1: New Technology Development
7.3.2: Capacity Expansion of the Global Genome Editing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Genome Editing Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Merck KGaA
8.2: Therm Fisher Scientific
8.3: Horizon Discovery
8.4: Lonza
8.5: GenScript
8.6: Eurofins Scientific
8.7: Company
8.8: Company
8.9: Company
8.10: Company
2. MARKET BACKGROUND AND CLASSIFICATIONS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2014 T 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Genome Editing Market Trends and Forecast
3.3: Global Genome Editing Market by Technology
3.3.1: CRISPR/Cas9
3.3.2: TALENs
3.3.3: ZFN
3.3.4: Others
3.4: Global Genome Editing Market by Delivery Method
3.4.1: Ex-Viv
3.4.2: In-Viv
3.5: Global Genome Editing Market by Application
3.5.1: Cell Line Engineering
3.5.2: Animal Genetic Engineering
3.5.3: Plant Genetic Engineering
3.5.4: Other Applications
3.6: Global Genome Editing Market by Service
3.6.1: Contract
3.6.2: In-House
3.7: Global Genome Editing Market by End Use
3.7.1: Biotechnology & Pharmaceutical Companies
3.7.2: Academic & Government Research Institutes
3.7.3: Contract Research Organizations
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION
4.1: Global Genome Editing Market by Region
4.2: North American Genome Editing Market
4.2.1: Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.2.2: Market by Delivery Method: Ex-Vivo and In-Vivo
4.2.3: Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.2.4: Market by Service: Contract and In-House
4.2.5: Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.2.6: The United States Genome Editing Market
4.2.7: The Canadian Genome Editing Market
4.2.8: The Mexican Genome Editing Market
4.3: European Genome Editing Market
4.3.1: Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.3.2: Market by Delivery Method: Ex-Vivo and In-Vivo
4.3.3: Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.2.4: Market by Service: Contract and In-House
4.2.5: Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.3.6: The United Kingdom Genome Editing Market
4.3.7: The Spanish Genome Editing Market
4.3.8: The German Genome Editing Market
4.3.9: The French Genome Editing Market
4.4: APAC Genome Editing Market
4.4.1: Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.4.2: Market by Delivery Method: Ex-Vivo and In-Vivo
4.4.3: Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.4.4: Market by Service: Contract and In-House
4.4.5: Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.4.6: The Chinese Genome Editing Market
4.4.7: The Indian Genome Editing Market
4.4.8: The Japanese Genome Editing Market
4.5: ROW Genome Editing Market
4.5.1: Market by Technology: CRISPR/Cas9, TALENs, ZFN, and Others
4.5.2: Market by Delivery Method: Ex-Vivo and In-Vivo
4.5.3: Market by Application: Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering, and Other Applications
4.5.4: Market by Service: Contract and In-House
4.5.5: Market by End Use: Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Contract Research Organizations
4.5.6: Brazilian Genome Editing Market
5. COMPETITOR ANALYSIS
5.1: Market Share Analysis
5.2: Technology Portfoli Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. COST STRUCTURE ANALYSIS
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Genome Editing Market by Technology
7.1.2: Growth Opportunities for the Global Genome Editing Market by Delivery Method
7.1.3: Growth Opportunities for the Global Genome Editing Market by Application
7.1.4: Growth Opportunities for the Global Genome Editing Market by Service
7.1.5: Growth Opportunities for the Global Genome Editing Market by End Use
7.1.6: Growth Opportunities for the Global Genome Editing Market by Region
7.2: Emerging Trends in the Global Genome Editing Market
7.3: Strategic Analysis
7.3.1: New Technology Development
7.3.2: Capacity Expansion of the Global Genome Editing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Genome Editing Market
7.3.4: Certification and Licensing
8. COMPANY PROFILES OF LEADING PLAYERS
8.1: Merck KGaA
8.2: Therm Fisher Scientific
8.3: Horizon Discovery
8.4: Lonza
8.5: GenScript
8.6: Eurofins Scientific
8.7: Company
8.8: Company
8.9: Company
8.10: Company
